Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.17B |
| 2 |
Microsoft
MSFT
|
+$619M |
| 3 |
Apple
AAPL
|
+$377M |
| 4 |
Booking.com
BKNG
|
+$319M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.48B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$896M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$599M |
| 4 |
Citigroup
C
|
+$467M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$430M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.29% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.55% |
| 4 | Financials | 1.15% |
| 5 | Healthcare | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNT
10951
Senstar Technologies
SNT
$38.3M
| $92K | ﹤0.01% |
73,008
+55,324
| +313% | +$84.6K |
|
10952
CALL
Arcos Dorados Holdings
ARCO
$1.69B
| $92K | ﹤0.01% |
11,000
-46,100
| -81% | -$345K |
|
|
BRDS
10953
DELISTED
Bird Global, Inc.
BRDS
| $91.9K | ﹤0.01% |
20,405
+17,100
| +517% | +$125K |
|
|
SEVN
10954
PUT
Seven Hills Realty Trust
SEVN
$172M
| $91.8K | ﹤0.01% |
+10,100
| New | +$94.2K |
|
|
ROVR
10955
PUT
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $91.8K | ﹤0.01% |
25,000
+2,600
| +12% | +$11.1K |
|
|
ALIM
10956
DELISTED
Alimera Sciences
ALIM
| $91.5K | ﹤0.01% |
+33,775
| New | +$144K |
|
|
RGF
10957
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $91.5K | ﹤0.01% |
+1,150
| New | +$93.8K |
|
10958
CALL
Xos
XOS
$47.8M
| $91.4K | ﹤0.01% |
6,923
-1,884
| -21% | -$48.5K |
|
10959
CALL
Greenlight Captial
GLRE
$502M
| $91.3K | ﹤0.01% |
+11,200
| New | +$87.4K |
|
10960
PUT
Nexa Resources
NEXA
$1.77B
| $91.1K | ﹤0.01% |
15,100
-5,700
| -27% | -$30.9K |
|
10961
CALL
FreightCar America
RAIL
$235M
| $90.9K | ﹤0.01% |
28,400
-84,200
| -75% | -$315K |
|
10962
Ultrapar
UGP
$6.87B
| $90.8K | ﹤0.01% |
+37,509
| New | +$93.8K |
|
10963
Urban One Class D
UONEK
$19.4M
| $90.8K | ﹤0.01% |
2,414
-340
| -12% | -$15.1K |
|
10964
PUT
Protalix BioTherapeutics
PLX
$205M
| $90.7K | ﹤0.01% |
66,200
-16,700
| -20% | -$18.3K |
|
10965
INmune Bio
INMB
$64.7M
| $90.6K | ﹤0.01% |
14,294
-9,479
| -40% | -$67.3K |
|
|
DBD
10966
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
| $90.6K | ﹤0.01% |
63,800
+31,200
| +96% | +$66.9K |
|
10967
EyePoint Inc
EYPT
$386M
| $90.5K | ﹤0.01% |
25,865
+13,084
| +102% | +$57.7K |
|
|
DBD
10968
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
| $90.5K | ﹤0.01% |
63,700
-39,900
| -39% | -$85.6K |
|
|
VZIO
10969
PUT
DELISTED
VIZIO Holding Corp.
VZIO
| $90.4K | ﹤0.01% |
12,200
-7,200
| -37% | -$69.7K |
|
10970
PUT
Recursion Pharmaceuticals
RXRX
$1.79B
| $90.2K | ﹤0.01% |
11,700
-3,300
| -22% | -$32.4K |
|
10971
CALL
Vanda Pharmaceuticals
VNDA
$320M
| $90.2K | ﹤0.01% |
12,200
-33,200
| -73% | -$323K |
|
|
LOGC
10972
PUT
DELISTED
ContextLogic
LOGC
| $90.1K | ﹤0.01% |
6,130
-38,127
| -86% | -$784K |
|
10973
Fuel Tech
FTEK
$46.2M
| $90K | ﹤0.01% |
70,877
+11,437
| +19% | +$14.7K |
|
|
CELL
10974
DELISTED
PhenomeX Inc. Common Stock
CELL
| $90K | ﹤0.01% |
33,579
+11,363
| +51% | +$30K |
|
10975
LiveWire
LVWR
$277M
| $89.8K | ﹤0.01% |
18,515
| – | – |
|
Similar funds
Jeff Yass's Q4 2022 Portfolio in Review
As of Q4 2022, Jeff Yass held 14,748 positions worth $395B, up 2.2% from $387B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q4 2022 filing shows 1,670 new, 4,598 increased, 5,764 reduced and 2,486 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M. The largest sale was Amazon, an estimated $1.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2022 buy was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M.
- Jeff Yass added most to Tesla in Q4 2022, an estimated $2.17B increase.
- Jeff Yass's biggest Q4 2022 reduction was Amazon, cutting an estimated $1.48B.
- Jeff Yass fully exited Twitter, Inc. in Q4 2022, selling an estimated $76M.
- Jeff Yass's ten largest holdings make up 27% of its $395B portfolio in Q4 2022.
- Jeff Yass opened 1,670 new positions and closed 2,486 in Q4 2022.
- Jeff Yass's portfolio value rose 2.2% quarter-over-quarter to $395B.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.